Civeo (NYSE: CVEO) insider transactions
In the twelve months to 10 November 2026, executives and directors of Civeo reported 8 open-market sales of 453,472 shares ($13.3m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 2 November 2026 | Dodson Bradley J | President & CEO | Open-market sale | −23,288 | $37.17 | 238,178 | Form 4 |
| 19 August 2026 | Fraser Andrew | President, Canada | Option exercise | +6,657 | — | 6,657 | Form 4 |
| 19 August 2026 | Fraser Andrew | President, Canada | Returned to the company | −6,657 | $33.94 | 0 | Form 4 |
| 27 May 2026 | Navarre Richard A | Director | Grant or award | +1,232 | — | 71,559 | Form 4 |
| 27 May 2026 | Blankenship C Ronald | Director | Grant or award | +3,624 | — | 54,446 | Form 4 |
| 27 May 2026 | Lambert Martin | Director | Grant or award | +3,624 | — | 40,060 | Form 4 |
| 27 May 2026 | Moore Constance B | Director | Grant or award | +3,624 | — | 49,983 | Form 4 |
| 27 May 2026 | Navarre Richard A | Director | Grant or award | +3,624 | — | 70,327 | Form 4 |
| 27 May 2026 | Montelongo Michael | Director | Grant or award | +3,624 | — | 25,522 | Form 4 |
| 27 May 2026 | Silvers Daniel B. | Director | Grant or award | +3,624 | — | 3,624 | Form 4 |
| 27 May 2026 | Wall Timothy O | Director | Grant or award | +3,624 | — | 21,813 | Form 4 |
| 27 May 2026 | Scofield Jeffrey | Director | Grant or award | +3,624 | — | 9,242 | Form 4 |
| 6 March 2026 | McCann Peter | SVP, Australia | Open-market sale | −4,000 | $28.64 | 50,942 | Form 4 |
| 3 March 2026 | Dodson Bradley J | President & CEO | Option exercise | +11,862 | — | 273,328 | Form 4 |
| 3 March 2026 | Dodson Bradley J | President & CEO | Returned to the company | −11,862 | $27.03 | 261,466 | Form 4 |
| 3 March 2026 | McCann Peter | SVP, Australia | Option exercise | +2,209 | — | 57,151 | Form 4 |
| 3 March 2026 | McCann Peter | SVP, Australia | Returned to the company | −2,209 | $27.03 | 54,942 | Form 4 |
| 3 March 2026 | Brewer Barclay | Chief Accounting Officer | Option exercise | +2,864 | — | 12,385 | Form 4 |
| 3 March 2026 | Brewer Barclay | Chief Accounting Officer | Returned to the company | −2,864 | $27.03 | 9,521 | Form 4 |
| 3 March 2026 | Gerry Elbridge Collin | SVP CFO and Treasurer | Option exercise | +2,691 | — | 5,958 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Civeo page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.